通过早期正确诊断、减少毒性死亡和防止治疗放弃来优化中低收入国家儿童非霍奇金淋巴瘤的结局
在高收入国家,超过90%的成熟B细胞淋巴瘤儿童可通过一线治疗治愈,但治愈需要及时正确的诊断、仔细的风险分层、非常强烈的化疗和细致的支持治疗,以及为远离癌症中心或面临经济障碍的患者提供后勤支持。在中低收入国家(LMIC),治愈率范围为20%至70%,原因包括缺乏诊断、误诊、放弃治疗、毒性死亡以及减强度方案导致的过多复发。幸运的是,LMIC中广泛的成功干预措施已减少了这些可避免的治疗失败原因:公众意识运动提高了社会对儿童癌症的认识;远程病理学改善了诊断,即使在偏远地区;补贴化疗、交通、住房和食物减少了放弃治疗;手卫生、护士培训计划和卫生系统改善减少了毒性死亡。这些干预措施可以在任何地方以低成本部署,因此具有高度可扩展性。通过及时正确诊断、应用适应当地情况的方案、防止治疗放弃和避免毒性死亡,伯基特淋巴瘤儿童和青少年在所有国家都可以被治愈。减少这些治疗失败原因在任何地方都是可行且高度成本效益的。
要点
- 在高收入国家,超过90%的成熟B细胞淋巴瘤儿童通过一线治疗治愈。
- 在中低收入国家,治愈率范围为20%至70%,原因包括缺乏诊断、误诊、放弃治疗、毒性死亡和减强度方案导致的过多复发。
- 公众意识运动、远程病理学、补贴化疗/交通/住房/食物、手卫生、护士培训和卫生系统改善等干预措施可减少可避免的治疗失败。
核心结论
- 通过及时正确诊断、应用适应当地情况的方案、防止治疗放弃和避免毒性死亡,伯基特淋巴瘤儿童和青少年在所有国家都可以被治愈。
- 减少这些治疗失败原因在任何地方都是可行且高度成本效益的。
研究设计与样本
- 原文未报告研究设计。
主要发现
- 在高收入国家,超过90%的成熟B细胞淋巴瘤儿童通过一线治疗治愈。
- 在中低收入国家,治愈率范围为20%至70%,原因包括缺乏诊断、误诊、放弃治疗、毒性死亡和减强度方案导致的过多复发。
- 公众意识运动提高了社会对儿童癌症的认识;远程病理学改善了诊断,即使在偏远地区;补贴化疗、交通、住房和食物减少了放弃治疗;手卫生、护士培训计划和卫生系统改善减少了毒性死亡。
- 这些干预措施可以在任何地方以低成本部署,因此具有高度可扩展性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In high-income countries, more than 90% of children with mature B-cell lymphomas are cured with frontline therapy. However, cure requires prompt and correct diagnosis, careful risk stratification, very intense chemotherapy and meticulous supportive care, together with logistical support for patients who live far from the cancer centre or face financial barriers to receiving care. In low- and middle-income countries (LMIC), cure rates range from 20% to 70% because of lack of diagnosis, misdiagnosis, abandonment of treatment, toxic death and excess relapse with reduced-intensity regimens. Fortunately, a wide range of successful interventions in LMIC have reduced these causes of avoidable treatment failure. Public awareness campaigns have led to societal awareness of childhood cancer; telepathology has improved diagnosis, even in remote areas; subsidized chemotherapy, transportation, housing and food have reduced abandonment; and hand hygiene, nurse training programmes and health system improvements have reduced toxic death. These interventions can be deployed everywhere and at low cost, so are highly scalable. Children and adolescents with Burkitt lymphoma can be cured in all countries by making a timely correct diagnosis, applying protocols adapted to the local context, preventing abandonment of therapy and avoiding toxic death. Reducing these causes of treatment failure is feasible and highly cost-effective everywhere.
引用
- Chantada G, Lam CG, Howard SC, et al. Optimizing outcomes for children with non-Hodgkin lymphoma in low- and middle-income countries by early correct diagnosis, reducing toxic death and preventing abandonment. Br J Haematol. 2019. PMID: 30740656. doi:10.1111/bjh.15785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。